Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Du

Showing results (881-890 of 932) with videos related to

Pageof 94
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groupsJ I Levin, J Chen, M Du, et al.
Arthritis and Rheumatism|November 30, 2006
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in sclerodermaRachel K Hoyles, Ross W Ellis, Jessica Wellsbury, et al.
Cell Death & Disease|October 30, 2015
A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cellsW Mughal, L Nguyen, S Pustylnik, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Thorax|March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
Respiratory Medicine|April 17, 2012
Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue diseaseAryeh Fischer, Joshua J Solomon, Roland M du Bois, et al.
Food Microbiology|May 22, 2012
The evaluation of a PCR-based method for identification of Salmonella enterica serotypes from environmental samples and various food matricesJunia Jean-Gilles Beaubrun, Chorng-Ming Cheng, Kai-Shun Chen, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 1, 2016
Postdischarge Care of Pediatric Traumatic Brain Injury in Argentina: A Multicenter Randomized Controlled TrialNancy A Carney, Gustavo J Petroni, Silvia B Luján, et al.
Zhonghua Yi Xue Za Zhi|July 24, 2023
[Survey of <i>Helicobacter pylori</i> levofloxacin and clarithromycin resistance rates and drug resistance genes in Ningxia, 2020-2022]L M Du, S J Hu, X M Chen, et al.
Pageof 94

Showing results (881-890 of 932) with videos related to

Sort By:
Pageof 94
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groupsJ I Levin, J Chen, M Du, et al.
Arthritis and Rheumatism|November 30, 2006
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in sclerodermaRachel K Hoyles, Ross W Ellis, Jessica Wellsbury, et al.
Cell Death & Disease|October 30, 2015
A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cellsW Mughal, L Nguyen, S Pustylnik, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Thorax|March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
Respiratory Medicine|April 17, 2012
Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue diseaseAryeh Fischer, Joshua J Solomon, Roland M du Bois, et al.
Food Microbiology|May 22, 2012
The evaluation of a PCR-based method for identification of Salmonella enterica serotypes from environmental samples and various food matricesJunia Jean-Gilles Beaubrun, Chorng-Ming Cheng, Kai-Shun Chen, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 1, 2016
Postdischarge Care of Pediatric Traumatic Brain Injury in Argentina: A Multicenter Randomized Controlled TrialNancy A Carney, Gustavo J Petroni, Silvia B Luján, et al.
Zhonghua Yi Xue Za Zhi|July 24, 2023
[Survey of <i>Helicobacter pylori</i> levofloxacin and clarithromycin resistance rates and drug resistance genes in Ningxia, 2020-2022]L M Du, S J Hu, X M Chen, et al.
Pageof 94